ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EX09 | B | Nintedanib - 150mg | 8524/388 | 161315/1 | OFEV | 150mg | 60 | Capsule, soft | Oral | Mersaco | Boehringer Ingelheim Pharma GmbH & Co KG | Germany | L.L | 2.44 | E2 | Boehringer Ingelheim International GmbH | Germany | 2/5/2024 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EX09 | B | Nintedanib - 150mg | 8524 | 161315/1 | OFEV | 150mg | 60 | Capsule, soft | Oral | Mersaco | Boehringer Ingelheim Pharma GmbH & Co KG | Germany | 233,109,926 L.L | 2.44 | E2 | Boehringer Ingelheim International GmbH | Germany | 2/5/2024 | 0 |